Prior to adjourning for its August ...

Prior to adjourning for its August reces Congres took action to clarify the feed and Drug Administration's authority to require sponsors to criterion drugs on children if the company falls to do in the same manner voluntarily. Policymakers have been lucky in encouraging more pediatric studies by means of offering an additional six month of exclusivity in succession products where manufacturers underwrite so research. FDA backed up the voluntary incentive program with a 1998 order mandating such studies. However, last year (17 October 2002) a federal court decided that FDA lacks authority to enforce like a ...